Conversely, intraarticular injection of CCL2 into the affected joints almost completely restored the severity of SAA-accelerated arthritis in LysM-Cre;Nfat5fl/fl mice compared with Nfat5fl/fl mice (Figure 7E). This evidence concerns the gene CCL2 and arthritic joint disease.